Next Article in Journal
Unravelling the Role of Trophoblastic-Derived Extracellular Vesicles in Regulatory T Cell Differentiation
Next Article in Special Issue
Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy
Previous Article in Journal
psbE-psbL and ndhA Intron, the Promising Plastid DNA Barcode of Fagopyrum
Previous Article in Special Issue
Expression and Functional Analyses of Dlk1 in Muscle Stem Cells and Mesenchymal Progenitors during Muscle Regeneration
Open AccessCommunication

Human Skeletal Muscle Cells Derived from the Orbicularis Oculi Have Regenerative Capacity for Duchenne Muscular Dystrophy

1
Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
2
Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan
3
Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
4
Department of Anatomy, Fujita Health University, Toyoake 470-1192, Japan
5
AMED-CREST, AMED 1-7-1 Otemachi, Chiyoda, Tokyo 100-0004, Japan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(14), 3456; https://doi.org/10.3390/ijms20143456
Received: 23 June 2019 / Revised: 10 July 2019 / Accepted: 11 July 2019 / Published: 14 July 2019
(This article belongs to the Special Issue Muscular Dystrophy: From Molecular Basis to Therapies)
Skeletal muscle stem cells (MuSCs) have been proposed as suitable candidates for cell therapy in muscular disorders since they exhibit good capacity for myogenic regeneration. However, for better therapeutic outcomes, it is necessary to isolate human MuSCs from a suitable tissue source with high myogenic differentiation. In this context, we isolated CD56+CD82+ cells from the extra eyelid tissue of young and aged patients, and tested in vitro myogenic differentiation potential. In the current study, myogenic cells derived from extra eyelid tissue were characterized and compared with immortalized human myogenic cells. We found that myogenic cells derived from extra eyelid tissue proliferated and differentiated myofibers in vitro, and restored DYSTROPHIN or PAX7 expression after transplantation with these cells in mice with Duchenne muscular dystrophy. Thus, human myogenic cells derived from extra eyelid tissue including the orbicularis oculi might be good candidates for stem cell-based therapies for treating muscular diseases. View Full-Text
Keywords: muscle stem cell; orbicularis oculi; cell transplantation; Duchenne muscular dystrophy muscle stem cell; orbicularis oculi; cell transplantation; Duchenne muscular dystrophy
Show Figures

Figure 1

MDPI and ACS Style

Yamanaka, Y.; Takenaka, N.; Sakurai, H.; Ueno, M.; Kinoshita, S.; Sotozono, C.; Sato, T. Human Skeletal Muscle Cells Derived from the Orbicularis Oculi Have Regenerative Capacity for Duchenne Muscular Dystrophy. Int. J. Mol. Sci. 2019, 20, 3456.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop